# Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population

> **NCT04500912** · NA · COMPLETED · sponsor: **Pieter C.Smits** · enrollment: 736 (actual)

## Conditions studied

- Cardiac Disease
- PCI
- High Bleeding Risk

## Interventions

- **DEVICE:** Supraflex Cruz 60 Micron
- **DEVICE:** Ultimaster Tansei 80 Micron

## Key facts

- **NCT ID:** NCT04500912
- **Lead sponsor:** Pieter C.Smits
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-14
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 736 (ACTUAL)
- **Last updated:** 2023-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04500912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04500912, "Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04500912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*